grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

December 05, 2011

Omnicell Will Showcase Recently Launched G4 Solutions at ASHP 2011 Conference

Download PDF


MOUNTAIN VIEW, Calif., Dec. 5, 2011 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today demonstrated its recently introduced Omnicell® G4 platform at the American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition at booth #131 in New Orleans, Louisiana. The new fourth generation suite of solutions includes its Automated Dispensing Cabinets with an integrated Medication Label Printer, Controlled Substance Management System (CSM), Savvy™ Mobile Medication System and the newly redesigned Anesthesia Workstation.

In addition, Omnicell is launching the new Pandora® Financials solution, featuring customizable analytics software for hospitals that presents actionable information regarding medication and supply inventory levels to maximize financial outcomes and efficiency.

"The host of new Omnicell products on display at ASHP demonstrates our commitment to develop industry-defining technology to help hospitals streamline workflows enterprise-wide and achieve essential cost savings, while supporting their goals to enhance patient safety," said Marga Ortigas-Wedekind, Omnicell vice president, global marketing and product development. "The Omnicell G4 platform features such innovations as a single unified medication database as well as Microsoft® Windows 7® to ensure system security and long-term support. The G4 solutions have generated considerable interest in the market since their introduction in May, and we are excited to showcase these exceptional products at ASHP, along with our new Pandora Financials analytics offering."

The new Pandora Financials solution presents actionable medication and supply inventory level information to hospitals, alleviating the time burden required for manual data analysis. Providers are now easily and efficiently able to access critical information such as total inventory costs of medications and supplies, location-specific inventory turns and costs per patient stay. The customization and flexibility built into the Pandora Financials application allows integration with Pandora® Clinicals on the PandoraVIA platform, granting providers access to the specific financial and clinical information they need to monitor diversion, help maintain medication dispensing compliance and optimize inventory and supply levels.

The new integrated Medication Label Printer, a unique Omnicell offering, supports accurate medication administration with patient-specific labels that are efficiently printed at the medication cabinet, helping to ensure compliance with the Joint Commission Standards.

Early customer experience highlights the utility of this medication administration solution. Spaulding Hospital Cambridge is proud to be on the cutting edge of technology as one of the first hospitals to use the integrated Medication Label Printer. "This product supports our goal to offer our patients high quality care while ensuring regulatory compliance," said Joseph Sacco, director of pharmacy at Spaulding Hospital Cambridge. "The Omnicell integrated Medication Label Printer is a useful tool which strengthens our process of providing the right medication at the point of care, while saving clinician time by being able to easily print drug labels when needed."

Omnicell's G4 platform includes the only automated dispensing system that is Modular EHR certified and works with all HIS vendors. The new platform's single unified database across the automated medication dispensing system decreases the risk of human error and saves significant pharmacy time by eliminating the need for repetitive entry of drug formularies in multiple locations. The G4 platform is designed to help hospitals closely manage medication and supply inventory to reduce costs, comply with increasingly stringent regulatory pressures and safeguard the patient.

About Spaulding Rehabilitation Network 
A member of Partners HealthCare, The Spaulding Rehabilitation Network includes Spaulding Rehabilitation Hospital-Boston (main campus), a 196-bed facility, as well as Spaulding Rehabilitation Hospital Cape Cod. Additional locations include the two long-term care facilities Spaulding Hospital Cambridge and Spaulding Hospital North Shore and two skilled nursing facilities, as well as twenty-three outpatient sites throughout the Greater Boston area. Spaulding is a teaching hospital of Harvard Medical School as well as the official rehabilitation hospital of the New England Patriots. Spaulding is the only rehabilitation hospital in New England continually ranked since 1995 by U.S. News and World Report in its Best Hospitals survey with a #5 ranking in 2011. For more information, please visit

About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automated and business information solutions enabling hospitals and healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a hospital's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, more than 2,500 hospital customers worldwide have relied on Omnicell's medication automation, supply chain, and hospital analytics solutions to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.

For more information about Omnicell, please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. OptiFlex is a trademark of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

SOURCE Omnicell, Inc.

News Provided by Acquire Media